Cargando…

Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic

The COVID-19 crisis has major impacted the insurance industry in three dimensions: business operations, underwriting and claims and insurance investing. This paper will analyse the implications for insurance investing. We start by showing the impact of the severe drawdown in the equity markets durin...

Descripción completa

Detalles Bibliográficos
Autor principal: Liedtke, Patrick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Palgrave Macmillan UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971357/
https://www.ncbi.nlm.nih.gov/pubmed/33758482
http://dx.doi.org/10.1057/s41288-021-00219-5
_version_ 1783666596525375488
author Liedtke, Patrick M.
author_facet Liedtke, Patrick M.
author_sort Liedtke, Patrick M.
collection PubMed
description The COVID-19 crisis has major impacted the insurance industry in three dimensions: business operations, underwriting and claims and insurance investing. This paper will analyse the implications for insurance investing. We start by showing the impact of the severe drawdown in the equity markets during the initial phase of the crisis in March/April 2020 on a typical insurer’s balance sheet. We then look at the effects of the dislocations in fixed income, which make up the largest share of exposures in insurance companies’ portfolios. We track the performance of investment grade credit during the year while paying special attention to the impact of downgrades on insurers’ solvency capital. We finally study alternative investments with particular focus on private markets. These investments are a faster-growing part of insurance companies’ exposures and pose specific challenges as they are complex, more difficult to access, have limited liquidity and are often harder to price, especially during times of high market volatility. Yet, compared to their equivalent public market exposures, private investments provide additional income, which allows insurers to charge lower rates on their products to policyholders. As the sophistication and complexity of investments keep growing, companies as well as regulators need to find a good balance between policyholder protection and market efficiency.
format Online
Article
Text
id pubmed-7971357
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Palgrave Macmillan UK
record_format MEDLINE/PubMed
spelling pubmed-79713572021-03-19 Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic Liedtke, Patrick M. Geneva Pap Risk Insur Issues Pract Article The COVID-19 crisis has major impacted the insurance industry in three dimensions: business operations, underwriting and claims and insurance investing. This paper will analyse the implications for insurance investing. We start by showing the impact of the severe drawdown in the equity markets during the initial phase of the crisis in March/April 2020 on a typical insurer’s balance sheet. We then look at the effects of the dislocations in fixed income, which make up the largest share of exposures in insurance companies’ portfolios. We track the performance of investment grade credit during the year while paying special attention to the impact of downgrades on insurers’ solvency capital. We finally study alternative investments with particular focus on private markets. These investments are a faster-growing part of insurance companies’ exposures and pose specific challenges as they are complex, more difficult to access, have limited liquidity and are often harder to price, especially during times of high market volatility. Yet, compared to their equivalent public market exposures, private investments provide additional income, which allows insurers to charge lower rates on their products to policyholders. As the sophistication and complexity of investments keep growing, companies as well as regulators need to find a good balance between policyholder protection and market efficiency. Palgrave Macmillan UK 2021-03-18 2021 /pmc/articles/PMC7971357/ /pubmed/33758482 http://dx.doi.org/10.1057/s41288-021-00219-5 Text en © The Geneva Association 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Liedtke, Patrick M.
Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic
title Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic
title_full Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic
title_fullStr Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic
title_full_unstemmed Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic
title_short Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic
title_sort vulnerabilities and resilience in insurance investing: studying the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971357/
https://www.ncbi.nlm.nih.gov/pubmed/33758482
http://dx.doi.org/10.1057/s41288-021-00219-5
work_keys_str_mv AT liedtkepatrickm vulnerabilitiesandresilienceininsuranceinvestingstudyingthecovid19pandemic